Orchard Therapeutics plc (16)

Browse by Contract Category

Contracts

Amendment to the Transitional Services Agreement, dated March 30, 2022, between the Company, Orchard Therapeutics North America and Frank Thomas (Filed With SEC on March 30, 2022)
Securities Purchase Agreement dated February 4, 2021, by and among Orchard Therapeutics plc and the Purchasers named therein (Filed With SEC on February 9, 2021)
Amendment Nos. 5 and 6 to License and Development Agreement, by and between the registrant and Oxford BioMedica (UK) Limited, dated November 28, 2016 (Filed With SEC on May 7, 2020)
2019 Short-Term Incentive Plan (Filed With SEC on May 7, 2020)
Description of the registrants securities (Filed With SEC on February 27, 2020)
Transitional Services Agreement, dated November 3, 2021, between the Company, Orchard Therapeutics North America and Frank Thomas (Filed With SEC on November 4, 2021)
Manufacturing and Technology Development Master Agreement, by and between Orchard Therapeutics (Europe) Limited, a wholly-owned subsidiary of the registrant, and MolMed S.p.A.,... (Filed With SEC on August 6, 2020)
Amendment to Senior Term Facilities Agreement by and between the registrant and MidCap Financial (Ireland) Limited, as agent, dated April 7, 2020 (Filed With SEC on May 7, 2020)
Settlement Agreement without Prejudice and Subject to Contract, dated March 17, 2020, by and among the Company, Orchard Therapeutics (Europe) Limited, Orchard Therapeutics North... (Filed With SEC on March 20, 2020)
Separation Agreement and Release, dated March 17, 2020, by and among the Company, Orchard Therapeutics North America and Mark Rothera (Filed With SEC on March 20, 2020)
Variation to Contract of Employment, dated March 18, 2020, by and between Orchard Therapeutics (Europe) Limited and Hubert Gaspar, M.D., Ph.D (Filed With SEC on March 20, 2020)
First Amendment to Employment Agreement, dated March 18, 2020, by and among the Company, Orchard Therapeutics North America and Frank Thomas (Filed With SEC on March 20, 2020)
Forms of award agreements under the 2018 Share Option and Incentive Plan (Filed With SEC on February 27, 2020)
Employment Agreement between the registrant, Orchard Therapeutics North America, and Mark Rothera, effective May 30, 2019 (Filed With SEC on February 27, 2020)
Employment Agreement between the registrant, Orchard Therapeutics North America, and Frank Thomas, effective September 1, 2019 (Filed With SEC on February 27, 2020)
Contract of Employment between Orchard Therapeutics (Europe) Limited and Hubert Gaspar, dated January 8, 2018, as amended effective May 24, 2019 (Filed With SEC on February 27, 2020)